At the time of writing, Vor Biopharma Inc [VOR] stock is trading at $2.5, up 8.23%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The VOR shares have gain 30.89% over the last week, with a monthly amount glided 989.32%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Vor Biopharma Inc [NASDAQ: VOR] stock has seen the most recent analyst activity on June 30, 2025, when H.C. Wainwright upgraded its rating to a Buy but kept the price target unchanged to $3 for it. Previously, Wedbush started tracking the stock with Outperform rating on July 26, 2022, and set its price target to $18. On April 27, 2022, Goldman initiated with a Neutral rating and assigned a price target of $6 on the stock. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $26 on December 17, 2021. Robert W. Baird initiated its recommendation with a Outperform and recommended $38 as its price target on December 03, 2021. Oppenheimer started tracking with a Outperform rating for this stock on December 02, 2021, and assigned it a price target of $30. In a note dated October 19, 2021, JMP Securities initiated an Mkt Outperform rating and provided a target price of $40 on this stock.
For the past year, the stock price of Vor Biopharma Inc fluctuated between $0.13 and $3.29. Currently, Wall Street analysts expect the stock to reach $3 within the next 12 months. Vor Biopharma Inc [NASDAQ: VOR] shares were valued at $2.5 at the most recent close of the market. An investor can expect a potential return of 20.0% based on the average VOR price forecast.
Analyzing the VOR fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.08, Equity is -1.42 and Total Capital is -1.32. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.47.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.25 points at the first support level, and at 2.01 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.79, and for the 2nd resistance point, it is at 3.09.
Ratios To Look Out For
It is important to note that Vor Biopharma Inc [NASDAQ:VOR] has a current ratio of 3.88. As well, the Quick Ratio is 3.88, while the Cash Ratio is 2.99.
Transactions by insiders
Recent insider trading involved Robert Ang, Officer, that happened on Jul 10 ’25 when 0.6 million shares were purchased. Officer, ROBERT ANG completed a deal on Jul 02 ’25 to buy 44936.0 shares. Meanwhile, Officer ROBERT ANG bought 40468.0 shares on Jul 01 ’25.
